Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Parkinson's Disease

  Free Subscription


Articles published in Ann Neurol

Retrieve available abstracts of 62 articles:
HTML format



Single Articles


    March 2020
  1. WHITE DL, Kunik ME, Yu H, Lin HL, et al
    Post-traumatic stress disorder is associated with further increased Parkinson's disease risk in veterans with traumatic brain injury.
    Ann Neurol. 2020 Mar 30. doi: 10.1002/ana.25726.
    PubMed     Abstract available


    February 2020
  2. MORO E, Bellot E, Meoni S, Pelissier P, et al
    Visual dysfunction of the superior colliculus in de novo Parkinsonian patients.
    Ann Neurol. 2020 Feb 6. doi: 10.1002/ana.25696.
    PubMed     Abstract available


    January 2020
  3. MATUSKEY D, Tinaz S, Wilcox KC, Naganawa M, et al
    Synaptic changes in Parkinson's disease assessed with in-vivo imaging.
    Ann Neurol. 2020 Jan 17. doi: 10.1002/ana.25682.
    PubMed     Abstract available


  4. KROHN L, Ozturk TN, Vanderperre B, Ouled Amar Bencheikh B, et al
    Genetic, Structural, and Functional Evidence Link TMEM175 to Synucleinopathies.
    Ann Neurol. 2020;87:139-153.
    PubMed     Abstract available


    September 2019
  5. MAETZLER W, Del Din S, Elshehabi M, Galna B, et al
    Reply to Quantitative motor functioning in prodromal Parkinson's Disease (ANA-19-0978).
    Ann Neurol. 2019 Sep 30. doi: 10.1002/ana.25605.
    PubMed    


  6. DOMMERSHUIJSEN LJ, Ikram MK, Darweesh SKL
    Quantitative motor functioning in prodromal Parkinson's disease.
    Ann Neurol. 2019 Sep 30. doi: 10.1002/ana.25606.
    PubMed    


    August 2019
  7. KUMMER BR, Diaz I, Wu X, Aaroe AE, et al
    Associations between cerebrovascular risk factors and parkinson disease.
    Ann Neurol. 2019 Aug 29. doi: 10.1002/ana.25564.
    PubMed     Abstract available


  8. MARIN-LAHOZ J, Sampedro F, Martinez-Horta S, Pagonabarraga J, et al
    Depression as a risk factor for impulse control disorders in Parkinson's disease.
    Ann Neurol. 2019 Aug 15. doi: 10.1002/ana.25581.
    PubMed     Abstract available


  9. DEMBEK TA, Roediger J, Horn A, Reker P, et al
    Probabilistic Sweetspots Predict Motor Outcome for DBS in Parkinson's Disease.
    Ann Neurol. 2019 Aug 3. doi: 10.1002/ana.25567.
    PubMed     Abstract available


  10. OUZREN N, Delcambre S, Ghelfi J, Seibler P, et al
    Mitochondrial DNA Deletions Discriminate Affected from Unaffected LRRK2 Mutation Carriers.
    Ann Neurol. 2019;86:324-326.
    PubMed    


  11. BAKSHI R, Macklin EA, Schwarzschild MA
    Reply to "Mitochondrial DNA deletions discriminate affected from unaffected LRRK2 mutation carriers".
    Ann Neurol. 2019;86:326-327.
    PubMed    


    July 2019
  12. GROZDANOV V, Bousset L, Hoffmeister M, Bliederhaeuser C, et al
    Increased immune activation by pathologic alpha-synuclein in Parkinson's Disease.
    Ann Neurol. 2019 Jul 25. doi: 10.1002/ana.25557.
    PubMed     Abstract available


  13. DEL DIN S, Elshehabi M, Galna B, Hobert M, et al
    Gait analysis with wearables predicts conversion to Parkinson's disease.
    Ann Neurol. 2019 Jul 11. doi: 10.1002/ana.25548.
    PubMed     Abstract available


    June 2019
  14. VOLLSTEDT EJ, Kasten M, Klein C
    Using global team science to identify genetic Parkinson's disease worldwide.
    Ann Neurol. 2019 Jun 2. doi: 10.1002/ana.25514.
    PubMed    


  15. SAIKI S, Sasazawa Y, Fujimaki M, Kamagata K, et al
    A metabolic profile of polyamines in Parkinson's disease: a promising biomarker.
    Ann Neurol. 2019 Jun 2. doi: 10.1002/ana.25516.
    PubMed     Abstract available


  16. STROTZER QD, Anthofer JM, Faltermeier R, Brawanski AT, et al
    Deep brain stimulation: Connectivity profile for bradykinesia alleviation.
    Ann Neurol. 2019;85:852-864.
    PubMed     Abstract available


    April 2019
  17. SCHULZ J, Takousis P, Wohlers I, Itua IOG, et al
    Meta-analyses identify differentially expressed microRNAs in Parkinson's disease.
    Ann Neurol. 2019 Apr 16. doi: 10.1002/ana.25490.
    PubMed     Abstract available


  18. WESTENBERGER A, Reyes CJ, Saranza G, Dobricic V, et al
    A hexanucleotide repeat modifies expressivity of X-linked dystonia-parkinsonism.
    Ann Neurol. 2019 Apr 11. doi: 10.1002/ana.25488.
    PubMed     Abstract available


  19. TROPEA TF, Mak J, Guo MH, Xie SX, et al
    TMEM106B Effect on Cognition in Parkinson's Disease and Frontotemporal Dementia.
    Ann Neurol. 2019 Apr 11. doi: 10.1002/ana.25486.
    PubMed     Abstract available


    March 2019
  20. SCHREINER SJ, Imbach LL, Werth E, Poryazova R, et al
    Slow-wave sleep and motor progression in Parkinson disease.
    Ann Neurol. 2019 Mar 18. doi: 10.1002/ana.25459.
    PubMed     Abstract available


    February 2019
  21. CHRISTINE CW, Bankiewicz KS, Van Laar AD, Richardson RM, et al
    MRI-guided Phase 1 Trial of Putaminal AADC Gene Therapy for Parkinson's Disease.
    Ann Neurol. 2019 Feb 25. doi: 10.1002/ana.25450.
    PubMed     Abstract available


  22. VAN RUMUND A, Green AJ, Fairfoul G, Esselink RA, et al
    Alpha-synuclein RT-QuIC in the CSF of uncertain cases of parkinsonism.
    Ann Neurol. 2019 Feb 23. doi: 10.1002/ana.25447.
    PubMed     Abstract available


  23. GOLDMAN SM, Marek K, Ottman R, Meng C, et al
    Concordance for Parkinson's Disease in Twins: a 20-Year Update.
    Ann Neurol. 2019 Feb 20. doi: 10.1002/ana.25441.
    PubMed     Abstract available


  24. BAKSHI R, Macklin EA, Logan R, Zorlu MM, et al
    Higher urate in LRRK2 mutation carriers resistant to Parkinson's disease.
    Ann Neurol. 2019 Feb 13. doi: 10.1002/ana.25436.
    PubMed     Abstract available


  25. BOHNEN NI, Kanel P, Zhou Z, Koeppe RA, et al
    Cholinergic system changes of falls and freezing of gait in Parkinson disease.
    Ann Neurol. 2019 Feb 5. doi: 10.1002/ana.25430.
    PubMed     Abstract available


  26. COUGHLIN D, Xie SX, Liang M, Williams A, et al
    Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
    Ann Neurol. 2019;85:259-271.
    PubMed     Abstract available


    November 2018
  27. DU G, Lewis MM, Sica C, Kong L, et al
    Magnetic resonance T1w/T2w ratio: A parsimonious marker for Parkinson's disease.
    Ann Neurol. 2018 Nov 8. doi: 10.1002/ana.25376.
    PubMed     Abstract available


    October 2018
  28. ESPAY AJ, Morgante F, Merola A, Fasano A, et al
    Levodopa-induced dyskinesia in Parkinson disease: Current and Evolving Concepts.
    Ann Neurol. 2018 Oct 24. doi: 10.1002/ana.25364.
    PubMed     Abstract available


  29. AMATO N, Manconi M, Moller JC, Sarasso S, et al
    Levodopa-induced dyskinesia in Parkinson's disease: sleep matters.
    Ann Neurol. 2018 Oct 17. doi: 10.1002/ana.25360.
    PubMed     Abstract available


    September 2018
  30. SEARLES NIELSEN S, Gross A, Camacho-Soto A, Willis AW, et al
    beta2-adrenoreceptor medications and risk of Parkinson disease.
    Ann Neurol. 2018 Sep 17. doi: 10.1002/ana.25341.
    PubMed     Abstract available


    August 2018
  31. PIHLSTROM L, Blauwendraat C, Cappelletti C, Berge-Seidl V, et al
    A comprehensive analysis of SNCA-related genetic risk in sporadic parkinson disease.
    Ann Neurol. 2018 Aug 26. doi: 10.1002/ana.25274.
    PubMed     Abstract available


    July 2018
  32. KIA DA, Noyce AJ, White J, Speed D, et al
    Mendelian randomization study shows no causal relationship between circulating urate levels and Parkinson's disease.
    Ann Neurol. 2018 Jul 16. doi: 10.1002/ana.25294.
    PubMed     Abstract available


  33. KOBYLECKI CJ, Nordestgaard BG, Afzal S
    Plasma urate and risk of Parkinson's disease: a Mendelian randomization study.
    Ann Neurol. 2018 Jul 16. doi: 10.1002/ana.25292.
    PubMed     Abstract available


    May 2018
  34. LUKIC S, Bisevac B, Krstic N
    Intriguing association of Parkinson disease and epileptic seizures.
    Ann Neurol. 2018 May 8. doi: 10.1002/ana.25257.
    PubMed    


  35. GRUNTZ K, Fuhr P, Meier C, Ruegg S, et al
    Reply to <<Intriguing association of Parkinson disease and epileptic seizures >>.
    Ann Neurol. 2018 May 8. doi: 10.1002/ana.25252.
    PubMed    


    April 2018
  36. KOTAGAL V, Spino C, Bohnen NI, Koeppe RA, et al
    Serotonin, beta-amyloid, and cognition in Parkinson disease.
    Ann Neurol. 2018 Apr 17. doi: 10.1002/ana.25236.
    PubMed     Abstract available


    March 2018
  37. JONIKAS M, Madill M, Mathy A, Zekoll T, et al
    Stem Cell modeling of Mitochondrial Parkinsonism reveals key functions of OPA1.
    Ann Neurol. 2018 Mar 31. doi: 10.1002/ana.25221.
    PubMed     Abstract available


    January 2018
  38. GRUNTZ K, Bloechliger M, Becker C, Jick SS, et al
    Parkinson's disease and the risk of epileptic seizures.
    Ann Neurol. 2018 Jan 25. doi: 10.1002/ana.25157.
    PubMed     Abstract available


    November 2017
  39. KAASINEN V, Vahlberg T
    Striatal dopamine in Parkinson's disease: A meta-analysis of imaging studies.
    Ann Neurol. 2017 Nov 22. doi: 10.1002/ana.25103.
    PubMed     Abstract available


  40. BURY AG, Pyle A, Elson JL, Greaves L, et al
    Mitochondrial DNA changes in pedunculopontine cholinergic neurons in Parkinson's.
    Ann Neurol. 2017 Nov 17. doi: 10.1002/ana.25099.
    PubMed     Abstract available


    October 2017
  41. LEE Y, Oh JS, Chung SJ, Chung SJ, et al
    Does Smoking Impact Dopamine Neuronal Loss in de novo Parkinson's Disease?
    Ann Neurol. 2017 Oct 23. doi: 10.1002/ana.25082.
    PubMed    


  42. CAMACHO-SOTO A, Warden MN, Searles Nielsen S, Salter A, et al
    Traumatic Brain Injury in the Prodromal Period of Parkinson Disease: A Large Epidemiological Study Using Medicare Data.
    Ann Neurol. 2017 Oct 10. doi: 10.1002/ana.25074.
    PubMed     Abstract available


  43. CHUANG YH, Lee PC, Vlaar T, Mulot C, et al
    Pooled analysis of the HLA-DRB1 by smoking interaction in Parkinson's disease.
    Ann Neurol. 2017 Oct 5. doi: 10.1002/ana.25065.
    PubMed     Abstract available


  44. SCHONHAUT DR, McMillan CT, Spina S, Dickerson BC, et al
    18 F-flortaucipir tau PET distinguishes established progressive supranuclear palsy from controls and Parkinson's disease: A multicenter study.
    Ann Neurol. 2017 Oct 5. doi: 10.1002/ana.25060.
    PubMed     Abstract available


    September 2017
  45. STORZER L, Butz M, Hirschmann J, Abbasi O, et al
    Bicycling suppresses abnormal beta synchrony in the Parkinsonian basal ganglia.
    Ann Neurol. 2017 Sep 11. doi: 10.1002/ana.25047.
    PubMed     Abstract available


  46. STRANIERO L, Guella I, Cilia R, Parkkinen L, et al
    DNAJC12 and dopa-responsive non-progressive Parkinsonism.
    Ann Neurol. 2017 Sep 11. doi: 10.1002/ana.25048.
    PubMed     Abstract available


    August 2017
  47. IRANZO A, Santamaria J, Valldeoriola F, Serradell M, et al
    Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic REM sleep behavior disorder.
    Ann Neurol. 2017 Aug 22. doi: 10.1002/ana.25026.
    PubMed     Abstract available


    June 2017
  48. HORN A, Reich M, Vorwerk J, Li N, et al
    Connectivity predicts deep brain stimulation outcome in Parkinson's disease.
    Ann Neurol. 2017 Jun 6. doi: 10.1002/ana.24974.
    PubMed     Abstract available


    May 2017
  49. MUSACCHIO T, Rebenstorff M, Fluri F, Brotchie JM, et al
    STN-DBS is neuroprotective in the A53T alpha-synuclein Parkinson's disease rat model.
    Ann Neurol. 2017 May 3. doi: 10.1002/ana.24947.
    PubMed     Abstract available


    April 2017
  50. SEIDEL K, Bouzrou M, Heidemann N, Kruger R, et al
    Involvement of the cerebellum in Parkinson's disease and Dementia with Lewy bodies.
    Ann Neurol. 2017 Apr 25. doi: 10.1002/ana.24937.
    PubMed     Abstract available


    March 2017
  51. CHEN X, Chen H, Cai W, Maguire M, et al
    The melanoma-linked "redhead" MC1R influences dopaminergic neuron survival.
    Ann Neurol. 2017;81:395-406.
    PubMed     Abstract available


    February 2017
  52. KAUFMANN H, Norcliffe-Kaufmann L, Palma JA, Biaggioni I, et al
    Natural history of pure autonomic failure: A United States prospective cohort.
    Ann Neurol. 2017;81:287-297.
    PubMed     Abstract available


    January 2017
  53. KORDOWER JH, Goetz CG, Chu Y, Halliday GM, et al
    Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient.
    Ann Neurol. 2017;81:46-57.
    PubMed     Abstract available


    December 2016
  54. PAGANO G, Niccolini F, Fusar-Poli P, Politis M, et al
    Serotonin transporter in Parkinson's disease: A meta-analysis of PET studies.
    Ann Neurol. 2016 Dec 26. doi: 10.1002/ana.24859.
    PubMed     Abstract available


  55. BRAKEDAL B, Haugarvoll K, Tzoulis C
    Simvastatin is associated with decreased risk of Parkinson Disease.
    Ann Neurol. 2016 Dec 26. doi: 10.1002/ana.24857.
    PubMed    


  56. YEN SJ, Lin KD
    Reply to "Simvastatin is associated with decreased risk of Parkinson Disease" by Brage Brakedal.
    Ann Neurol. 2016 Dec 26. doi: 10.1002/ana.24862.
    PubMed    


    October 2016
  57. LIN KD, Shin SJ
    Reply to 'Risk reduction of Parkinson disease by statin therapy in patients with diabetes' by T. Kawada.
    Ann Neurol. 2016 Oct 31. doi: 10.1002/ana.24813.
    PubMed    


  58. KAWADA T
    Risk reduction of Parkinson disease by statin therapy in patients with diabetes.
    Ann Neurol. 2016 Oct 27. doi: 10.1002/ana.24809.
    PubMed    


  59. STANDAERT DG, Geldmacher DS
    GBA, Parkinson disease, and the "senses and intellect".
    Ann Neurol. 2016 Oct 25. doi: 10.1002/ana.24808.
    PubMed    


  60. INZELBERG R, Flash S, Friedman E, Azizi E, et al
    Cutaneous malignant melanoma and Parkinson's disease: common pathways?
    Ann Neurol. 2016 Oct 19. doi: 10.1002/ana.24802.
    PubMed     Abstract available


    September 2016
  61. LIU G, Boot B, Locascio JJ, Jansen IE, et al
    Neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's.
    Ann Neurol. 2016 Sep 22. doi: 10.1002/ana.24781.
    PubMed     Abstract available


  62. CILIA R, Tunesi S, Marotta G, Cereda E, et al
    Survival and dementia in GBA-associated Parkinson Disease: The mutation matters.
    Ann Neurol. 2016 Sep 15. doi: 10.1002/ana.24777.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: